Faculty profile

Michael Tymianski

ResearcherUniversity of Toronto

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Toronto directory, so their courses may be missing. Find their university profile.

Michael Tymianski

Researcher

Health Sciences

University of Toronto

Toronto, Ontario, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
41 publications in the last five years, latest in 2026.
Senior (last) author on 5 recent papers, a sign of leading a research group.
Principal investigator on 2 research grants (2 CIHR), most recently in 2017.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

129

Publications

1,088

Citations

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Crc

Latest papers

Brain-derived tau for monitoring brain injury in acute ischemic stroke
Science Translational Medicine · 2026
Sex differences in brain frailty measures and outcomes after endovascular thrombectomy: ESCAPE-NA1 analysis
Journal of the Neurological Sciences · 2026
Safety and Efficacy of Nerinetide at Year 1 in Participants Enrolled in ESCAPE‐NEXT: A Multicenter, Double‐Blind, Randomized Controlled Trial
Journal of the American Heart Association · 2026 · senior author

All 129 publications

Latest funding

Canada Research Chair - Tier 1
CIHR · 2017 · Nominated PI
$1,400,000
Canadian Stroke Network (2006 Renewal Competition)
NSERC · 2013 · Co-investigator
$500,000
CANADA RESEARCH CHAIRHOLDER – TIER 1 / TITULAIRE DE CHAIRE DE RECHERCHE DU CANADA – NIVEAU 1
CIHR · 2010 · Nominated PI
$1,400,000

All 4 grants and awards

129 publications.

Brain-derived tau for monitoring brain injury in acute ischemic stroke

Vlegels N, Knuth NL, Steiner KA, Zhang L, Vix AL, Moumin D, Mirzen I, Khalifeh N, Forster C, Gesierich B

Science Translational Medicine20267 citations

DOI: 10.1126/scitranslmed.adz1280

Sex differences in brain frailty measures and outcomes after endovascular thrombectomy: ESCAPE-NA1 analysis

Fujiwara S, Fladt J, Benali F, Bala F, Singh N, Nogueira R, McTaggart RA, Demchuk AM, Poppe AY, Rempel JL

Journal of the Neurological Sciences20264 citations

DOI: 10.1016/j.jns.2026.126070

Safety and Efficacy of Nerinetide at Year 1 in Participants Enrolled in ESCAPE‐NEXT: A Multicenter, Double‐Blind, Randomized Controlled Trial

Adams C, Heard K, Kohli Y, Vatanpour S, Berrouschot J, Buck B, Demchuk A, Dippel D, Dorn F, Field T

Journal of the American Heart Association2026Senior author

DOI: 10.1161/jaha.125.044080

Health economic impact of Nerinetide in addition to mechanical thrombectomy without concurrent alteplase.

Ospel JM, Adams C, Tymianski M, Goyal M, Hill M

Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences2026

DOI: 10.1177/15910199231193455 PMID: 37590087

Minimal Sufficient Balance Randomization and Site-Specific Treatment Allocation Imbalance in Multicenter Acute Stroke Trials.

Biziaev T, Hill MD, Johns H, Tymianski M, Adams C, Churilov L, Menon BK, Sajobi TT

Stroke2026

DOI: 10.1161/strokeaha.126.055315 PMID: 42100801

Predicting outcome in acute stroke with large vessel occlusion-application and validation of MR PREDICTS in the ESCAPE-NA1 population.

Marko M, Goyal M, Ospel JM, Singh N, Venema E, Nogueira RG, Demchuk AM, McTaggart RA, Poppe AY, Menon BK, Zerna C, Mulder M, Dippel DW, Lingsma HF, Roozenbeek B, Tymianski M, Hill MD

Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences2026

DOI: 10.1177/15910199231221491 PMID: 38115793

MRI measurement of the delayed secondary ischaemic injury following endovascular thrombectomy: results from the REPERFUSE-NA1 study.

Tadros GS, Fladt J, Wang M, Guo J, Specht JL, McTaggart RA, Swartz RH, Field TS, Shah R, Goyal M, Hill MD, Demchuk AM, Tymianski M, d'Esterre CD, Barber PA

European stroke journal2026

DOI: 10.1093/esj/aakag032 PMID: 41955072

Efficacy and safety of nerinetide in acute ischaemic stroke in patients undergoing endovascular thrombectomy without previous thrombolysis (ESCAPE-NEXT): a multicentre, double-blind, randomised controlled trial

Hill MD, Goyal M, Demchuk AM, Menon BK, Field TS, Guest WC, Berrouschot J, Bormann A, Pham M, Haeusler KG

The Lancet202566 citationsSenior author

DOI: 10.1016/s0140-6736(25)00194-1

Safety and efficacy of nerinetide in patients with acute ischaemic stroke enrolled in the early window: a post-hoc meta-analysis of individual patient data from three randomised trials

Tymianski M, Hill MD, Goyal M, Christenson J, Menon BK, Swartz RH, Adams C, Heard K, Kohli Y, Aamodt AH

Lancet Neurology202541 citationsFirst author

DOI: 10.1016/s1474-4422(24)00515-5

Impact of Brain Frailty on Clinical Presentation and Neurologic Recovery in Acute Ischemic Stroke Patients Undergoing Thrombectomy

Fladt J, Benali F, Jaroenngarmsamer T, Bala F, Singh N, Nogueira RG, McTaggart R, Demchuk A, Poppe A, Buck BH

Neurology202516 citations

DOI: 10.1212/wnl.0000000000213619

Something wrong or missing on this profile? Suggest a correction

Michael Tymianski

Research

Latest papers

Latest funding

Brain-derived tau for monitoring brain injury in acute ischemic stroke

Sex differences in brain frailty measures and outcomes after endovascular thrombectomy: ESCAPE-NA1 analysis

Safety and Efficacy of Nerinetide at Year 1 in Participants Enrolled in ESCAPE‐NEXT: A Multicenter, Double‐Blind, Randomized Controlled Trial

Health economic impact of Nerinetide in addition to mechanical thrombectomy without concurrent alteplase.

Minimal Sufficient Balance Randomization and Site-Specific Treatment Allocation Imbalance in Multicenter Acute Stroke Trials.

Predicting outcome in acute stroke with large vessel occlusion-application and validation of MR PREDICTS in the ESCAPE-NA1 population.

MRI measurement of the delayed secondary ischaemic injury following endovascular thrombectomy: results from the REPERFUSE-NA1 study.

Efficacy and safety of nerinetide in acute ischaemic stroke in patients undergoing endovascular thrombectomy without previous thrombolysis (ESCAPE-NEXT): a multicentre, double-blind, randomised controlled trial

Safety and efficacy of nerinetide in patients with acute ischaemic stroke enrolled in the early window: a post-hoc meta-analysis of individual patient data from three randomised trials

Impact of Brain Frailty on Clinical Presentation and Neurologic Recovery in Acute Ischemic Stroke Patients Undergoing Thrombectomy

Canada Research Chair - Tier 1

Canadian Stroke Network (2006 Renewal Competition)

CANADA RESEARCH CHAIRHOLDER – TIER 1 / TITULAIRE DE CHAIRE DE RECHERCHE DU CANADA – NIVEAU 1

Canadian Stroke Network (2006 Renewal Competition)

Frequent collaborators

Mayank Goyal

Aravind Ganesh

Brian Van Adel

Ivan Radovanovic

Nishita Singh

Dar Dowlatshahi

Andrew Demchuk

Nishita Singh

Demetrios Sahlas

Hong-Shuo Sun

Michael Tymianski

Houman Khosravani

Mohammed Almekhlafi

Brian Buck

Johanna Ospel

Bijoy Menon

Kuan Huei Ng

Wes Oczkowski

Sumiti Nayar

Wu Qiu

Alexandre Poppe

David Mikulis

Richard Swartz

Michael Hill

Sashi Perera

Gustavo Saposnik

Dariush Dowlatshahi

Aravind Ganesh

James Duffin

Joseph Fisher

Danielle De Sa Boasquevisque

Ashkan Shoamanesh

Raed Joundi

George Ibrahim

Clement Hamani

Marat Slessarev

Bijoy Menon

Benjamin Davidson

Philip Barber

Luciana Catanese